Gobalto, Inc.
Software Engineer
Dayspring Technologies, Inc. Feb 2015 - Jul 2019
Developer
Dev Bootcamp Jun 2014 - Aug 2014
Recent Graduate
Education:
College of Mount Saint Vincent 2006 - May 2010
Bachelors, Bachelor of Arts, Media Studies, Communication
Skills:
Javascript Ruby on Rails Ruby Css Html5 Web Development Marketing Photoshop Leadership Advertising Html 5 Indesign Microsoft Office Css3 Mysql Facebook Php Cascading Style Sheets Wordpress After Effects Git Angular2 Adobe Audition Html Jquery Cakephp Symfony Framework
Interests:
Skiing Environment Education Avid Reader Dog Person Poet Photography Science and Technology Surfing Hiking I Love Rock Climbing Actor Artist Human Rights Animal Welfare Arts and Culture
Celgene
Director
Bristol-Myers Squibb
Group Leader
Genentech Sep 2012 - Jan 2015
Qc Senior Scientist
Medimmune Jan 1, 2009 - Sep 2012
Scientist Ii at Medimmune
Amgen 2006 - 2009
Scientist
Education:
Oregon Health & Science University 1998 - 2002
Doctorates, Doctor of Philosophy, Molecular Biology, Philosophy
The Ohio State University 1984 - 1989
Bachelors, Bachelor of Science, Molecular Biology, Biochemistry
Skills:
Analytical Method Development and Validation For Biotherapeutics Cell Based Assays Cell Biology Molecular and Cellular Biology Immunoassays Impurities Cell Lines Cell Signaling Recombinant Dna Cell Line Engineering Protein Characterization Protein Purification Life Sciences Virology Automation Neuroscience Molecular Oncology Target Validation Targeted Drug Delivery Protein Expression Protein Engineering
Certifications:
Prevent Workplace Harassment
Us Patents
Inhibiting Her2 Shedding With Matrix Metalloprotease Antagonists
- South San Francisco CA, US Kendall CAREY - South San Francisco CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
G01N 33/68 C07K 16/28 G01N 33/50
Abstract:
The present invention provides a cell-based assay for identifying and/or quantifying anti-CD3 homodimers in a composition comprising a T cell-dependent Bispecific antibody (TDB). In some aspects, the invention T cells comprising a T cell activation responsive reporter are contacted with the TDB to detect the presence of anti-CD3 homodimers. Compositions of reporter T cells and kits are also contemplated.
Methods For Assaying T-Cell Dependent Bispecific Antibodies
- South San Francisco CA, US Guoying JIANG - South San Francisco CA, US Pin Yee WONG - South San Francisco CA, US Kendall CAREY - South San Francisco CA, US
International Classification:
G01N 33/68 C12Q 1/66 G01N 33/50 C07K 16/28
Abstract:
The present invention provides a cell-based assay for measuring T cell activation mediated by a T cell -dependent bispecific antibody (TDB). In some aspects, the assay is useful for detecting a TDB in a composition, quantitating the amount of TDB in a composition, determining the potency and/or specificity of a TDB, or determining if a population of cells expresses a target antigen. Compositions and kits are also contemplated.
Cell-Based Assay For Detecting Anti-Cd3 Homodimers
- South San Francisco CA, US Kendall CAREY - South San Francisco CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
G01N 33/68 C07K 16/28
Abstract:
The present invention provides a cell-based assay for identifying and/or quantifying anti-CD3 homodimers in a composition comprising a T cell-dependent Bispecific antibody (TDB). In some aspects, the invention T cells comprising a T cell activation responsive reporter are contacted with the TDB to detect the presence of anti-CD3 homodimers. Compositions of reporter T cells and kits are also contemplated.